WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008101309) CREATINE-FATTY ACIDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/101309    International Application No.:    PCT/CA2007/000257
Publication Date: 28.08.2008 International Filing Date: 20.02.2007
IPC:
C07C 279/14 (2006.01)
Applicants: MULTI FORMULATIONS LTD. [CA/CA]; 381 North Service Road West, Oakville, Ontario L6M 0H4 (CA) (For All Designated States Except US).
CHAUDHURI, Shan [CA/CA]; (CA) (For US Only).
MACDOUGALL, Joseph [CA/CA]; (CA) (For US Only).
PETERS, Jason [CA/CA]; (CA) (For US Only).
RAMSBOTTOM, James [CA/CA]; (CA) (For US Only)
Inventors: CHAUDHURI, Shan; (CA).
MACDOUGALL, Joseph; (CA).
PETERS, Jason; (CA).
RAMSBOTTOM, James; (CA)
Agent: TORYS LLP; 79 Wellington Street West, Suite 3000, Box 270, TD Centre, Toronto, Ontario M5K 1N2 (CA)
Priority Data:
Title (EN) CREATINE-FATTY ACIDS
(FR) COMPOSÉS CRÉATINE-ACIDES GRAS
Abstract: front page image
(EN)The present invention describes compounds produced from a creatine molecule and a fatty acid molecule. The compounds being in the form of creatine-fatty acid compounds being bound by an anhydride linkage, or mixtures thereof made by reacting creatine or derivatives thereof with an appropriate fatty acid previously reacted with a thionyl halide. The administration of such molecules provides supplemental creatine with enhanced bioavailability and the additional benefits conferred by the specific fatty acid. Formula (I).
(FR)La présente invention porte sur des composés obtenus à partir d'une molécule de créatine et d'une molécule d'acide gras. Ces composés se présentent sous la forme de composés créatine-acide gras liés par une liaison anhydride, ou de mélanges de ceux-ci, obtenus par réaction de créatine ou de dérivés de celle-ci avec un acide gras approprié ayant préalablement réagi avec un halogénure de thionyle. L'administration de telles molécules fournit une créatine supplémentaire à biodisponibilité accrue et avantages supplémentaires conférés par l'acide gras spécifique. Formula (I).
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)